Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C Signaling

Journal of Biological Chemistry

Volumn 288, Issue 49, 2013, Pages 35372-35386

  Verma, Sunil K ^a   Deshmukh, Vaibhav ^a   Liu, Patrick ^c   Nutter, Curtis A ^a   Espejo, Rosario ^a   Hung, Ming Lung ^d   Wang, Guey Shin ^d   Yeo, Gene W ^b,c   Kuyumcu Martinez, Muge N ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE SPLICING; PROTEIN KINASE C; RNA-BINDING PROTEIN;

PROTEINS;

C (PROGRAMMING LANGUAGE);

PROTEIN CELF1; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN RBFOX2; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETOGENESIS; EMBRYO; ENZYME REACTIVATION; FEMALE; GENE EXPRESSION REGULATION; GENE SWITCHING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA METABOLISM; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ALTERNATIVE SPLICING; DIABETES; HEART DEVELOPMENT; PROTEIN KINASE C (PKC); RNA-BINDING PROTEIN; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; CELLS, CULTURED; DIABETIC CARDIOMYOPATHIES; FEMALE; FETUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN KINASE C BETA; PROTEIN KINASE C-ALPHA; RATS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84890288947     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.507426     Document Type: Article

References (88)

1. Salsali, A., and Nathan, M. (2006) A review of types 1 and 2 diabetes mellitus and their treatment with insulin. Am. J. Ther. 13, 349-361
2. Aneja, A., Tang, W. H., Bansilal, S., Garcia, M. J., and Farkouh, M. E. (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am. J. Med. 121, 748-757
3. Ferrannini, E., and Cushman, W. C. (2012) Diabetes and hypertension: the bad companions. Lancet 380, 601-610
4. Harcourt, B. E., Penfold, S. A., and Forbes, J. M. (2013) Coming full circle in diabetes mellitus: from complications to initiation. Nat. Rev. Endocrinol. 9, 113-123
5. Boudina, S., and Abel, E. D. (2010) Diabetic cardiomyopathy, causes and effects. Rev. Endocr. Metab. Disord. 11, 31-39
6. Liu, Q., Chen, X., Macdonnell, S. M., Kranias, E. G., Lorenz, J. N., Leitges, M., Houser, S. R., and Molkentin, J. D. (2009) Protein kinase C-, but not PKC- or PKC-, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ. Res. 105, 194-200
7. Geraldes, P., and King, G. L. (2010) Activation of protein kinaseCisoforms and its impact on diabetic complications. Circ. Res. 106, 1319-1331
8. Inoguchi, T., Battan, R., Handler, E., Sportsman, J. R., Heath, W., and King, G. L. (1992) Preferential elevation of protein kinase C isoform -II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. U.S.A. 89, 11059-11063
9. Connelly, K. A., Kelly, D. J., Zhang, Y., Prior, D. L., Advani, A., Cox, A. J., Thai, K., Krum, H., and Gilbert, R. E. (2009) Inhibition of protein kinase C- by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ. Heart Fail. 2, 129-137
10. Liu, Y., Lei, S., Gao, X., Mao, X., Wang, T., Wong, G. T., Vanhoutte, P. M., Irwin, M. G., and Xia, Z. (2012) PKC- inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Clin. Sci. 122, 161-173
11. Kuyumcu-Martinez, N. M., Wang, G. S., and Cooper, T. A. (2007) Increased steady state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 28, 68-78
12. Revil, T., Toutant, J., Shkreta, L., Garneau, D., Cloutier, P., and Chabot, B. (2007) Protein kinase C-dependent control of Bcl-x alternative splicing. Mol. Cell. Biol. 27, 8431-8441
13. Zhao, Y., Koebis, M., Suo, S., Ohno, S., and Ishiura, S. (2012) Regulation of the alternative splicing of sarcoplasmic reticulum Ca2-ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway. Biochem. Biophys. Res. Commun. 423, 212-217
14. Zhou, Z., Qiu, J., Liu, W., Zhou, Y., Plocinik, R. M., Li, H., Hu, Q., Ghosh, G., Adams, J. A., Rosenfeld, M. G., and Fu, X. D. (2012) The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol. Cell 47, 422-433
15. Black, D. L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336
16. Kornblihtt, A. R., Schor, I. E., Alló, M., Dujardin, G., Petrillo, E., and Muñoz, M. J. (2013) Alternative splicing: A pivotal step between eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol. 14, 153-165
17. Wang, G. S., Kuyumcu-Martinez, M. N., Sarma, S., Mathur, N., Wehrens, X. H., and Cooper, T. A. (2009) PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. J. Clin. Invest. 119, 3797-3806
18. Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B., and Cooper, T. A. (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. U.S.A. 105, 20333-20338
19. Koshelev, M., Sarma, S., Price, R. E., Wehrens, X. H., and Cooper, T. A. (2010) Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum. Mol. Genet. 19, 1066-1075
20. Yeo, G. W., Coufal, N. G., Liang, T. Y., Peng, G. E., Fu, X. D., and Gage, F. H. (2009) An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 16, 130-137
21. Gallagher, T. L., Arribere, J. A., Geurts, P. A., Exner, C. R., McDonald, K. L., Dill, K. K., Marr, H. L., Adkar, S. S., Garnett, A. T., Amacher, S. L., and Conboy, J. G. (2011) Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. Dev. Biol. 359, 251-261
22. Gehman, L. T., Meera, P., Stoilov, P., Shiue, L., O'Brien, J. E., Meisler, M. H., Ares, M., Jr., Otis, T. S., and Black, D. L. (2012) The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. Genes Dev. 26, 445-460
23. Han, H., Irimia, M., Ross, P. J., Sung, H. K., Alipanahi, B., David, L., Golipour, A., Gabut, M., Michael, I. P., Nachman, E. N., Wang, E., Trcka, D., Thompson, T., O'Hanlon, D., Slobodeniuc, V., Barbosa-Morais, N. L., Burge, C. B., Moffat, J., Frey, B. J., Nagy, A., Ellis, J., Wrana, J. L., and Blencowe, B. J. (2013) MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 498, 241-245
24. Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., and Swanson, M. S. (2003) A muscleblind knockout model for myotonic dystrophy. Science 302, 1978-1980
25. Kimes, B. W., and Brandt, B. L. (1976) Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98, 367-381
26. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675
27. Wu, K. K., and Huan, Y. (2008) Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. Chapter 5, Unit 5.47
28. Bland, C. S., Wang, E. T., Vu, A., David, M. P., Castle, J. C., Johnson, J. M., Burge, C. B., and Cooper, T. A. (2010) Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res. 38, 7651-7664
29. Katz, Y., Wang, E. T., Airoldi, E. M., and Burge, C. B. (2010) Analysis and design ofRNAsequencing experiments for identifying isoform regulation. Nat. Methods 7, 1009-1015
30. Van Belle, T. L., Taylor, P., and von Herrath, M. G. (2009) Mouse models for type 1 diabetes. Drug Discov. Today Dis. Models 6, 41-45
31. Yu, X., Tesiram, Y. A., Towner, R. A., Abbott, A., Patterson, E., Huang, S., Garrett, M. W., Chandrasekaran, S., Matsuzaki, S., Szweda, L. I., Gordon, B. E., and Kem, D. C. (2007) Early myocardial dysfunction in streptozotocin- induced diabetic mice: A study using in vivo magnetic resonance imaging (MRI). Cardiovasc. Diabetol. 6, 6
32. Tochino, Y. (1987) The NOD mouse as a model of type I diabetes. Crit. Rev. Immunol. 8, 49-81
33. Ménard, C., Pupier, S., Mornet, D., Kitzmann, M., Nargeot, J., and Lory, P. (1999) Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J. Biol. Chem. 274, 29063-29070
34. Davis, P. D., Elliott, L. H., Harris, W., Hill, C. H., Hurst, S. A., Keech, E., Kumar, M. K., Lawton, G., Nixon, J. S., and Wilkinson, S. E. (1992) Inhibitors of protein kinase C. Substituted bisindolylmaleimides with improved potency and selectivity. J. Med. Chem. 35, 994-1001
35. Aderem, A. (1992) The MARCKS brothers: A family of protein kinase C substrates. Cell 71, 713-716
36. Moore, S. F., van den Bosch, M. T., Hunter, R. W., Sakamoto, K., Poole, A. W., and Hers, I. (2013) Dual regulation of glycogen synthase kinase 3 (GSK3) -/- by protein kinase C (PKC) - and Akt promotes thrombinmediated integrin -IIb-3 activation and granule secretion in platelets. J. Biol. Chem. 288, 3918-3928
37. Moraes, K. C., Wilusz, C. J., and Wilusz, J. (2006) CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA 12, 1084-1091
38. Timchenko, N. A., Wang, G. L., and Timchenko, L. T. (2005) RNA CUGbinding protein 1 increases translation of 20-kDa isoform of CCAAT/ enhancer-binding protein - by interacting with the - and - subunits of eukaryotic initiation translation factor J. Biol. Chem. 280, 20549-20557
39. Revil, T., Gaffney, D., Dias, C., Majewski, J., and Jerome-Majewska, L. A. (2010) Alternative splicing is frequent during early embryonic development in mouse. BMC Genomics 11, 399
40. Kalsotra, A., Wang, K., Li, P. F., and Cooper, T. A. (2010) MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 24, 653-658
41. Nakahata, S., and Kawamoto, S. (2005) Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res. 33, 2078-2089
42. Underwood, J. G., Boutz, P. L., Dougherty, J. D., Stoilov, P., and Black, D. L. (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol. Cell. Biol. 25, 10005-10016
43. Ramirez-Correa, G. A., Cortassa, S., Stanley, B., Gao, W. D., and Murphy, A. M. (2010) Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites. J. Mol. Cell. Cardiol. 48, 943-953
44. Sumandea, M. P., Pyle, W. G., Kobayashi, T., de Tombe, P. P., and Solaro, R. J. (2003) Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J. Biol. Chem. 278, 35135-35144
45. Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B., Bodi, I., Wang, S., Schwartz, A., Lakatta, E. G., DePaoli-Roach, A. A., Robbins, J., Hewett, T. E., Bibb, J. A., Westfall, M. V., Kranias, E. G., and Molkentin, J. D. (2004) PKC- regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248-254
46. Keren, H., Lev-Maor, G., and Ast, G. (2010) Alternative splicing and evolution: diversification, exon definition and function. Nat. Rev. Genet. 11, 345-355
47. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., and Burge, C. B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476
48. Yeo, G., Holste, D., Kreiman, G., and Burge, C. B. (2004) Variation in alternative splicing across human tissues. Genome Biol. 5, R74
49. Lewis, B. P., Green, R. E., and Brenner, S. E. (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Nal. Acad. Sci. U.S.A. 100, 189-192
50. Moore, M. J., and Proudfoot, N. J. (2009) Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136, 688-700
51. Salomonis, N., Nelson, B., Vranizan, K., Pico, A. R., Hanspers, K., Kuchinsky, A., Ta, L., Mercola, M., and Conklin, B. R. (2009) Alternative splicing in the differentiation of human embryonic stem cells into cardiac precursors. PLoS Comput. Biol. 5, e1000553
52. Depre, C., Young, M. E., Ying, J., Ahuja, H. S., Han, Q., Garza, N., Davies, P. J., and Taegtmeyer, H. (2000) Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J. Mol. Cell. Cardiol. 32, 985-996
53. Taegtmeyer, H., Sen, S., and Vela, D. (2010) Return to the fetal gene program: A suggested metabolic link to gene expression in the heart. Ann. N.Y. Acad. Sci. 1188, 191-198
54. Razeghi, P., Young, M. E., Alcorn, J. L., Moravec, C. S., Frazier, O. H., and Taegtmeyer, H. (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104, 2923-2931
55. Sadoshima, J., and Izumo, S. (1997) The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551-571
56. Ytrehus, K., Liu, Y., and Downey, J. M. (1994) Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266, H1145-H1152
57. Heineke, J., and Molkentin, J. D. (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600
58. Koya, D., and King, G. L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866
59. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820
60. Elwess, N. L., Filoteo, A. G., Enyedi, A., and Penniston, J. T. (1997) Plasma membrane Ca2- pump isoforms 2a and 2b are unusually responsive to calmodulin and Ca2-. J. Biol. Chem. 272, 17981-17986
61. Strehler, E. E., Caride, A. J., Filoteo, A. G., Xiong, Y., Penniston, J. T., and Enyedi, A. (2007) Plasma membrane Ca2- ATPases as dynamic regulators of cellular calcium handling. Ann. N.Y. Acad. Sci. 1099, 226-236
62. Oppelt, A., Lobert, V. H., Haglund, K., Mackey, A. M., Rameh, L. E., Liestøl, K., Schink, K. O., Pedersen, N. M., Wenzel, E. M., Haugsten, E. M., Brech, A., Rusten, T. E., Stenmark, H., and Wesche, J. (2013) Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration. EMBO Rep. 14, 57-64
63. Walker, D. M., Urbé, S., Dove, S. K., Tenza, D., Raposo, G., and Clague, M. J. (2001) Characterization of MTMR3. An inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol. 11, 1600-1605
64. Disatnik, M. H., Jones, S. N., and Mochly-Rosen, D. (1995) Stimulus-dependent subcellular localization of activated protein-kinase-C-a study with acidic fibroblast growth-factor and transforming growth-factor-1 in cardiac myocytes. J. Mol. Cell. Cardiol. 27, 2473-2481
65. Martelli, A. M., Evangelisti, C., Nyakern, M., and Manzoli, F. A. (2006) Nuclear protein kinase C. Biochim. Biophys. Acta 1761, 542-551
66. James, G., and Olson, E. (1992) Deletion of the regulatory domain of protein kinase C- exposes regions in the hinge and catalytic domains that mediate nuclear targeting. J. Cell Biol. 116, 863-874
67. Mochly-Rosen, D., Das, K., and Grimes, K. V. (2012) Protein kinase C, an elusive therapeutic target Nat. Rev. Drug Discov. 11, 937-957
68. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
69. Kobayashi, Y., Hirawa, N., Tabara, Y., Muraoka, H., Fujita, M., Miyazaki, N., Fujiwara, A., Ichikawa, Y., Yamamoto, Y., Ichihara, N., Saka, S., Wakui, H., Yoshida, S., Yatsu, K., Toya, Y., Yasuda, G., Kohara, K., Kita, Y., Takei, K., Goshima, Y., Ishikawa, Y., Ueshima, H., Miki, T., and Umemura, S. (2012) Mice lacking hypertension candidate gene ATP2B1 in vascular smooth muscle cells show significant blood pressure elevation. Hypertension 59, 854-860
70. Alzugaray, M. E., García, M. E., Del Zotto, H. H., Raschia, M. A., Palomeque, J., Rossi, J. P., Gagliardino, J. J., and Flores, L. E. (2009) Changes in islet plasma membrane calcium-ATPase activity and isoform expression induced by insulin resistance. Arch. Biochem. Biophys. 490, 17-23
71. Van't Padje, S., Chaudhry, B., Severijnen, L. A., van der Linde, H. C., Mientjes, E. J., Oostra, B. A., and Willemsen, R. (2009) Reduction in fragile X related 1 protein causes cardiomyopathy and muscular dystrophy in zebrafish. J. Exp. Biol. 212, 2564-2570
72. Xia, X. B., Xiong, S. Q., Song, W. T., Luo, J., Wang, Y. K., and Zhou, R. R. (2008) Inhibition of retinal neovascularization by siRNA targeting VEGF(165). Mol. Vis. 14, 1965-1973
73. Taimeh, Z., Loughran, J., Birks, E. J., and Bolli, R. (2013) Vascular endothelial growth factor in heart failure. Nat. Rev. Cardiol. 10, 519-530
74. Bhagavatula, M. R., Fan, C., Shen, G. Q., Cassano, J., Plow, E. F., Topol, E. J., and Wang, Q. (2004) Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 13, 3181-3188
75. Wang, L., Fan, C., Topol, S. E., Topol, E. J., and Wang, Q. (2003) Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302, 1578-1581
76. Mora, S., and Pessin, J. E. (2000) The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J. Biol. Chem. 275, 16323-16328
77. Ramsdell, A. F. (2005) Left-right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left-right axis determination. Dev. Biol. 288, 1-20
78. Feng, T., and Zhu, X. (2010) Genome-wide searching of rare genetic variants in WTCCC data. Hum. Genet. 128, 269-280
79. Hershberger, R. E., Parks, S. B., Kushner, J. D., Li, D., Ludwigsen, S., Jakobs, P., Nauman, D., Burgess, D., Partain, J., and Litt, M. (2008) Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin. Transl. Sci. 1, 21-26
80. Arrington, C. B., Dowse, B. R., Bleyl, S. B., and Bowles, N. E. (2012) Nonsynonymous variants in pre-B cell leukemia homeobox (PBX) genes are associated with congenital heart defects. Eur. J. Med. Genet. 55, 235-237
81. Stankunas, K., Shang, C., Twu, K. Y., Kao, S. C., Jenkins, N. A., Copeland, N. G., Sanyal, M., Selleri, L., Cleary, M. L., and Chang, C. P. (2008) Pbx/ Meis deficiencies demonstrate multigenetic origins of congenital heart disease. Circ. Res. 103, 702-709
82. Novarino, G., Akizu, N., and Gleeson, J. G. (2011) Modeling human disease in humans: the ciliopathies. Cell 147, 70-79
83. Guzzo, R. M., Salih, M., Moore, E. D., and Tuana, B. S. (2005) Molecular properties of cardiac tail-anchored membrane protein SLMAP are consistent with structural role in arrangement of excitation-contraction coupling apparatus. Am. J. Physiol. Heart Circ. Physiol. 288, H1810-H1819
84. Nader, M., Westendorp, B., Hawari, O., Salih, M., Stewart, A. F., Leenen, F. H., and Tuana, B. S. (2012) Tail-anchored membrane protein SLMAP is a novel regulator of cardiac function at the sarcoplasmic reticulum. Am. J. Physiol. Heart Circ. Physiol. 302, H1138-H1145
85. Ding, H., Howarth, A. G., Pannirselvam, M., Anderson, T. J., Severson, D. L., Wiehler, W. B., Triggle, C. R., and Tuana, B. S. (2005) Endothelial dysfunction in type 2 diabetes correlates with deregulated expression of the tail-anchored membrane protein SLMAP. Am. J. Physiol. Heart Circ. Physiol. 289, H206-H211
86. Lin,W. H., Chiu, K. C., Chang, H. M., Lee, K. C., Tai, T. Y., and Chuang, L. M. (2001) Molecular scanning of the human sorbin and SH3-domain- containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum. Mol. Genet. 10, 1753-1760
87. Terenzi, F., and Ladd, A. N. (2010) Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulatesMBNLlocalization and activity. RNA Biol. 7, 43-55
88. Blackwell, E., Zhang, X., and Ceman, S. (2010) Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA. Hum. Mol. Genet. 19, 1314-1323